3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
2
CNS
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Ovarian Neoplasms
45
Uterine Cervical Neoplasms
22
Fallopian Tube Neoplasms
20
Carcinoma, Ovarian Epithelial
15
Neoplasms
8
Endometrial Neoplasms
8
Lung Neoplasms
7
Breast Neoplasms
5
Stomach Neoplasms
4
Recurrence
4
Pancreatic Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Head and Neck Neoplasms
4
Gestational Trophoblastic Disease
4
Vulvar Neoplasms
3
Peritoneal Neoplasms
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Uterine Neoplasms
2
Sarcoma
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Laryngeal Neoplasms
2
Hydatidiform Mole
2
Gynecologic Cancer
2
Glioblastoma
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Interventions
Carboplatin
17
Filgrastim
16
Ifosfamide
13
Etoposide
13
Paclitaxel
11
Peripheral Blood Stem Cell Transplantation
10
Cisplatin
6
Thiotepa
5
Therapeutics
5
Cyclophosphamide
5
Temozolomide
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Granulocyte Colony-Stimulating Factor
4
Flow Cytometry
4
Bleomycin
4
Taxes
3
Radiotherapy
3
Methylprednisolone
3
Magnetic Resonance Spectroscopy
3
Amplified Fragment Length Polymorphism Analysis
3
Amifostine
3
sargramostim
2
pegfilgrastim
2
liposomal amphotericin B
2
ixabepilone
2
etoposide phosphate
2
aldesleukin
2
aflibercept
2
Trastuzumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Testicular Neoplasms
×
Drug Therapy
×
Gynecologic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled